Compassionate Pain Relief Act - Directs the Secretary of Health and Human Services to establish a program under which heroin shall be made available to individuals for the relief of pain from terminal cancer. Directs the Secretary, acting through the Commissioner of the Food and Drug Administration, to provide for the manufacture of heroin for such program. Directs the Attorney General to promulgate regulations making heroin available for use in such program. Directs the Secretary to assure the purity of such drug.

Permits physicians, hospital pharmacies, and hospice pharmacies registered under the Controlled Substances Act to prescribe heroin to terminally ill cancer patients.

Requires the registration, by the Attorney General, of: (1) manufacturers of heroin to be used in the program; (2) hospice and hospital pharmacies which dispense such drug; and (3) physicians who prescribe it.

Provides penalties for those who knowingly violate regulations prescribed by the Secretary.

Requires the Secretary to report to specified congressional committees regarding: (1) activities under the program; and (2) research and training in pain management funded by the National Institutes of Health.

Provides for the program's termination.